Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial. - Levy C; Abouda GF; Bilir BM; Bonder A; Bowlus CL; Campos-Varela I; Cazzagon N; Chandok N; Cheent K; Cortez-Pinto H; Demir M; Dill MT; et al. (Journal of hepatology, 2026)